Greiner Bio-One Introduces Test for High-Risk HPV Types
At MEDICA 2010 in Dusseldorf, Greiner Bio-One GmbH is unveiling the new PapilloCheck high-risk test system to augment the existing biochips product portfolio.
Read MoreMonth: November 2010
Sekisui to Buy Genzyme Diagnostics
Genzyme Corporation has entered into an asset purchase agreement under which Sekisui Chemical Co, Ltd will acquire Genzymes Diagnostic products business for $265 million in cash.
Read MoreMcKesson EHR Suite Earns Complete Certification
McKessons Horizon Clinicals has received complete EHR certificationdeeming the software capable or meeting the Stage 1 meaningful use measures required to qualify for funding under the ARRA.
Read MoreBioCision Signs Product Distribution Agreement with SANYO
BioCision LLC recently signed a product distribution agreement with SANYO E&E Europe BV.
Read MoreGene Screening May Refine Prediction of Heart Attack Risk
Testing for 11 specific genetic variations in hundreds of people with no history of heart disease provided information that led to revision of their estimated heart attack risk.
Read More